|
WDR5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.107000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.269600E-01 |
| Normal-vs-Stage2 |
5.374800E-01 |
| Normal-vs-Stage3 |
6.282600E-01 |
| Normal-vs-Stage4 |
6.095400E-01 |
| Stage1-vs-Stage2 |
7.882000E-01 |
| Stage1-vs-Stage3 |
3.972000E-01 |
| Stage1-vs-Stage4 |
4.795600E-01 |
| Stage2-vs-Stage3 |
4.051800E-01 |
| Stage2-vs-Stage4 |
3.824800E-01 |
| Stage3-vs-Stage4 |
9.230000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.965000E-01 |
| Normal-vs-AfricanAmerican |
6.813200E-01 |
| Normal-vs-Asian |
8.445700E-02 |
| Caucasian-vs-AfricanAmerican |
4.227600E-01 |
| Caucasian-vs-Asian |
2.605000E-01 |
| AfricanAmerican-vs-Asian |
3.205800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.322000E-01 |
| Normal-vs-Female |
3.680600E-01 |
| Male-vs-Female |
3.948800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.031800E-01 |
| Normal-vs-Extreme_Weight |
8.697400E-01 |
| Normal-vs-Obese |
3.883800E-01 |
| Normal-vs-Extreme_Obese |
9.170800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.960400E-01 |
| Normal_Weight-vs-Obese |
4.352200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.831800E-01 |
| Extreme_Weight-vs-Obese |
3.456000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.837600E-01 |
| Obese-vs-Extreme_Obese |
6.416800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.091820E-01 |
| Normal-vs-Age(41-60Yrs) |
8.634100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.721600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.279600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.065600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.804200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.839600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.075500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.353380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.526000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.587700E-02 |
| Normal-VS-Type2 PRCC |
1.769860E-02 |
| Normal-VS-KIRP CIMP |
1.822440E-01 |
| Normal-VS-Unclassified PRCC |
9.742600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.038130E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.862430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.347000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.651700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.075900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.896500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.494630E-01 |
| Normal-vs-N1 |
8.366100E-02 |
| Normal-vs-N2 |
9.748200E-01 |
| N0-vs-N1 |
2.053500E-02 |
| N0-vs-N2 |
6.086400E-01 |
| N1-vs-N2 |
4.914600E-01 |
|
|
